Loading…
Attending this event?
avatar for Kathleen Winson

Kathleen Winson

Genentech, A Member of the Roche Group, United States
Executive Group Director, Product Development Regulatory
Kathleen Winson is an Executive Group Director in Regulatory at Genentech/Roche. In her role, she oversees regulatory strategy for Oncology Lung and pan-tumor development. With over 25 years of experience in clinical research and drug development, Kathleen has garnered extensive expertise in both biotech/pharmaceutical and academic settings. Her knowledge spans numerous therapeutic areas, including cardiovascular health, neuroscience, immunology, infectious diseases, and oncology. Over the past decade, Kathleen has been leveraging her development expertise to advance innovative approaches aimed at optimizing and accelerating drug development.

My Speakers Sessions

Monday, June 17
 

3:30pm PDT

#154: Impact of Accelerated Pathways on Patients in Five Countries/Regions Room 11AB
 
Share Modal

Share this link via

Or copy link